Anavex Life Sciences (AVXL) Accumulated Expenses (2018 - 2026)
Anavex Life Sciences (AVXL) posted Accumulated Expenses of $4.04 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 2.7% from $3.93 million a year earlier and up 8.1% from the prior quarter.
Anavex Life Sciences (AVXL) Accumulated Expenses (2018 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Anavex Life Sciences' Accumulated Expenses came in at $3.89 million, down 19.5% from FY2024.
- Annual Accumulated Expenses shows a five-year compound annual growth rate of 3.3% (FY2020 to FY2025).
- In prior fiscal years, Anavex Life Sciences' Accumulated Expenses was $4.84 million in FY2024 (-33.7%), $7.3 million in FY2023 (+22.7%), $5.95 million in FY2022 (+5.9%) and $5.61 million in FY2021 (+69.3%).
- The fiscal Q3 2026 figure stands as the highest quarterly Accumulated Expenses since fiscal Q2 2025.
- On a year-over-year basis, Accumulated Expenses increased in three of the last eight quarters, with an average decline of 14.9%.
- The strongest year-over-year quarter for Accumulated Expenses in the past five years was fiscal Q2 2025, with growth of 94.4%; the weakest was fiscal Q1 2026, with a decline of 62.1%.
- According to Business Quant data, Accumulated Expenses for the three prior fiscal quarters was $3.73 million (Q2 2026), $2.93 million (Q1 2026) and $3.89 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Anavex Life Sciences | 168.71 Mn | -311.37 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.04 Mn |
| Mar 31, 2026 | 3.73 Mn |
| Dec 31, 2025 | 2.93 Mn |
| Sep 30, 2025 | 3.89 Mn |
| Jun 30, 2025 | 3.93 Mn |
| Mar 31, 2025 | 9.56 Mn |
| Dec 31, 2024 | 7.73 Mn |
| Sep 30, 2024 | 4.84 Mn |
| Jun 30, 2024 | 7.33 Mn |
| Mar 31, 2024 | 4.92 Mn |
| Dec 31, 2023 | 7.29 Mn |
| Sep 30, 2023 | 7.30 Mn |
| Jun 30, 2023 | 5.99 Mn |
| Mar 31, 2023 | 6.82 Mn |
| Dec 31, 2022 | 7.04 Mn |
| Sep 30, 2022 | 5.95 Mn |
| Jun 30, 2022 | 5.91 Mn |
| Mar 31, 2022 | 5.00 Mn |
| Dec 31, 2021 | 5.45 Mn |
| Sep 30, 2021 | 5.61 Mn |
Anavex Life Sciences Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=AVXL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();